Navigation Links
Prenatal Multivitamins to prevent risk of Brain Tumors In Kids

A recent study revealed that the risk of development of certain types of brain tumor in children could be reduced by the intake of multivitamins in the early stages of pregnancy.//

It is already known that multivitamins containing folic acid should be taken in the early stages of pregnancy to reduce the risk of development of a neural tube defect like spina bifida in the fetus.

"This current study suggests another possible protective effect for the vitamins," said study leader Greta R. Bunin, Ph.D., of The Children's Hospital of Philadelphia. She added, "Children whose mothers took multivitamins close to the time of conception seemed less likely to suffer medulloblastoma and primitive neuroectodermal tumors of the brain."

Medulloblastoma is the second most common brain tumor in kids. However, childhood brain tumors are rare. Medulloblastoma occurs in one in 20,000 children under age 6, it develops in the cerebellum, the lower portion of the brain, and the area of the brain that coordinates movement. A different part of the central nervous system is affected by Primitive neuroectodermal tumors of the brain (PNET), which are similar to medulloblastoma.

Dr.Bunin and her team conducted a comparative study on 315 children diagnosed with those tumors before age six and equal number of their normal counterparts. The Children's Oncology Group, a multicenter collaborative organization of pediatric cancer programs in the U.S. and Canada had enrolled the kids with cancer chosen for this study. These kids were diagnosed between 1991 and 1997. A telephone survey was conducted in which the mothers were interrogated.

"Children whose mothers took multivitamins close to the time of conception seemed less likely to suffer medulloblastoma and primitive neuroectodermal tumours of the brain," said Dr. Bunin.
The study was published in the September issue of Cancer Epidemiology Biomarkers & Prevention. The results were similar to a previous study conducted by the same team in 1993. Hence, they conclude that the obvious advantages could not have occurred by chance. However, the study revealed that taking multivitamins later in pregnancy did not much reduce the child's risk of medulloblastoma and PNET.

"Our findings suggest that the time close to conception may be a critical period in the development of these tumors," said Dr. Bunin. "However, most women do not yet know they are pregnant at this very early stage. That is why women of reproductive age are advised to take multivitamins to prevent neural tube defects even if they are not trying to get pregnant."

The mothers’ interrogation included the frequency of consumption of cured meats that have compounds shown to cause nervous system tumors in animals. No rise in risk of tumor was found in kids of mothers who often consumed those meats during pregnancy.

"Taking multivitamins in the first few weeks of pregnancy definitely helps prevent neural tube defects," concluded Dr. Bunin. "While more research remains to be done, our findings suggest that multivitamins may prevent some brain tumors as well."

This research was supported by the National Cancer Institute, part of the National Institutes of Health. Paul R. Gallagher, Lucy B. Rorke-Adams, M.D., and Avital Cnaan, Ph.D., all of The Children's Hospital of Philadelphia, with Leslie R. Robison, Ph.D., of St. Jude Children's Research Hospital, Memphis, Tenn. Drs. Bunin and Cnaan and faculty members of the University of Pennsylvania School of Medicine were Dr. Bunin's co-authors.
GYT
'"/>




Related medicine news :

1. The Safety Of Prenatal Ultrasounds Questioned
2. More Importance To Be Given To Prenatal Nutrition
3. Prenatal exposure to air pollution causes chromosomal damage
4. Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years
5. Personal Growth and Success Dependent on Prenatal Health
6. Prenatal Test and Miscarriage
7. Prenatal multivitamins reduce birth defects
8. Simple Blood Test may Replace Invasive Prenatal Tests
9. Hope for Noninvasive Prenatal Test
10. New Approach to Routine Prenatal Genetic Testing
11. Harmful Effects Of Glucocorticoids On Newborns Owing To Prenatal Exposure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: